News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
107,465 Results
Type
Article (4247)
Company Profile (19)
Press Release (103199)
Section
Business (31979)
Career Advice (108)
Deals (5251)
Drug Delivery (5)
Drug Development (5401)
Employer Resources (11)
FDA (3199)
Job Trends (2077)
News (46962)
Policy (3871)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
Academia (363)
Allergies (9)
Alliances (11156)
ALS (5)
Alzheimer's disease (301)
Antibody-drug conjugate (ADC) (2)
Approvals (3207)
Artificial intelligence (76)
Automation (3)
Bankruptcy (46)
Best Places to Work (1719)
Biosimilars (6)
Biotechnology (11)
Bladder cancer (7)
Brain cancer (5)
Breast cancer (49)
Cancer (338)
Cardiovascular disease (20)
Career advice (99)
Career pathing (1)
CAR-T (9)
Cell therapy (19)
Cervical cancer (3)
Clinical research (4146)
Collaboration (146)
Compensation (14)
COVID-19 (479)
C-suite (25)
Cystic fibrosis (8)
Data (190)
Decentralized trials (1)
Depression (4)
Diabetes (16)
Diagnostics (5763)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (12)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (4)
Earnings (10388)
Employer branding (2)
Employer resources (11)
Events (13453)
Executive appointments (90)
FDA (3355)
Featured Employer (3)
Fibrodysplasia Ossificans Progressiva (1)
Funding (114)
Gene editing (1)
Generative AI (8)
Gene therapy (13)
GLP-1 (38)
Government (624)
Guidances (4)
Healthcare (2909)
IgA nephropathy (1)
Immunology and inflammation (5)
Indications (1)
Infectious disease (503)
Inflammatory bowel disease (12)
Influenza (9)
Intellectual property (4)
Interviews (12)
IPO (1792)
IRA (1)
Job creations (401)
Job search strategy (94)
Kidney cancer (4)
Labor market (1)
Layoffs (24)
Leadership (1)
Legal (533)
Liver cancer (11)
Lung cancer (36)
Lymphoma (27)
Management (3)
Manufacturing (40)
MASH (4)
Medical device (2449)
Medtech (2449)
Mergers & acquisitions (3524)
Metabolic disorders (30)
Multiple sclerosis (15)
NASH (3)
Neurodegenerative disease (10)
Neuropsychiatric disorders (1)
Neuroscience (348)
NextGen: Class of 2025 (702)
Non-profit (546)
Northern California (300)
Now hiring (2)
Obesity (10)
Opinion (11)
Ovarian cancer (12)
Pain (3)
Pancreatic cancer (7)
Parkinson's disease (13)
Partnered (3)
Patents (16)
Patient recruitment (8)
Peanut (4)
People (8929)
Pharmaceutical (1)
Phase I (1256)
Phase II (1742)
Phase III (1589)
Pipeline (92)
Podcasts (1)
Policy (1)
Postmarket research (212)
Preclinical (589)
Press Release (11)
Prostate cancer (30)
Psychedelics (1)
Radiopharmaceuticals (120)
Rare diseases (27)
Real estate (861)
Recruiting (5)
Regulatory (2992)
Reports (10)
Research institute (425)
Resumes & cover letters (15)
Schizophrenia (1)
Series A (14)
Series B (11)
Service/supplier (2)
Sickle cell disease (1)
Southern California (241)
Sponsored (5)
Startups (622)
Stomach cancer (2)
Supply chain (3)
The Weekly (1)
United States (2672)
Vaccines (35)
Venture capitalists (5)
Weight loss (4)
Women's health (5)
Date
Today (27)
Last 7 days (104)
Last 30 days (524)
Last 365 days (5165)
2025 (983)
2024 (5119)
2023 (6130)
2022 (10210)
2021 (9619)
2020 (8993)
2019 (6148)
2018 (4857)
2017 (5401)
2016 (5389)
2015 (6110)
2014 (4629)
2013 (4128)
2012 (4435)
2011 (4630)
2010 (4081)
Location
Africa (131)
Alabama (6)
Alaska (1)
Arizona (50)
Arkansas (2)
Asia (5306)
Australia (1238)
California (644)
Canada (239)
China (27)
Colorado (47)
Connecticut (57)
Delaware (4)
Europe (15094)
Florida (81)
Georgia (35)
Idaho (4)
Illinois (86)
India (4)
Indiana (27)
Iowa (3)
Japan (18)
Kansas (11)
Kentucky (4)
Louisiana (1)
Maine (20)
Maryland (85)
Massachusetts (359)
Michigan (62)
Minnesota (70)
Missouri (24)
Montana (4)
Nebraska (8)
Nevada (1)
New Hampshire (18)
New Jersey (123)
New Mexico (17)
New York (252)
North Carolina (174)
North Dakota (6)
Northern California (300)
Ohio (22)
Oklahoma (2)
Oregon (6)
Pennsylvania (72)
Rhode Island (3)
South America (153)
South Carolina (2)
Southern California (241)
Tennessee (24)
Texas (140)
Utah (71)
Virginia (34)
Washington D.C. (5)
Washington State (59)
Wisconsin (26)
107,465 Results for "genecentric diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GeneCentric Therapeutics Launches EXpressCT Liquid Biopsy Platform
October 28, 2024
·
3 min read
Bio NC
GeneCentric Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
GeneCentric Therapeutics today announced upcoming presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Illinois from May 31st to June 4th.
May 20, 2024
·
2 min read
Bio NC
GeneCentric Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2024
GeneCentric Therapeutics today announced upcoming presentations at the American Association for Cancer Research Annual Meeting 2024 being held in San Diego, California from April 5-10.
April 1, 2024
·
2 min read
Business
GeneCentric Therapeutics Appoints Prasanth Reddy and Don Hardison to the Board of Directors as the Company Advances Its Oncology Diagnostics Pipeline
GeneCentric Therapeutics today announced the appointment of Prasanth Reddy, MD, MPH, FACP, and Don Hardison as independent directors of its Board of Directors.
November 14, 2023
·
2 min read
News
GeneCentric Therapeutics Announces Publication of Clinicogenomic Results from GARNER Study in High-Risk Non-Muscle Invasive Bladder Cancer
October 1, 2024
·
3 min read
Bio NC
GeneCentric Therapeutics Announces Upcoming Presentations at the American Society of Clinical Oncology Genitourinary Cancers Symposium and Precision Medicine World Conference
GeneCentric Therapeutics today announced upcoming presentations at the Precision Medicine World Conference (PMWC) in Santa Clara, California from January 24-26 and the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), which will be held January 25-27 in San Francisco, California.
January 22, 2024
·
3 min read
Bio NC
GeneCentric Therapeutics Announces Commercial Availability of PurIST℠ Test for Pancreatic Cancer
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today that its PurIST℠ test is now commercially available through Tempus for clinical use.
May 31, 2023
·
3 min read
Business
GeneCentric Therapeutics Appoints Brian Kelly as SVP Business Development
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced the appointment of Brian Kelly as Senior Vice President of Business Development.
April 12, 2023
·
2 min read
Partnered
Ending the Diagnostic Odyssey for Patients
Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.
December 11, 2024
·
4 min read
·
BioSpace Insights
Business
GeneCentric Therapeutics Announces Publication of New Results Showing Clinical Benefit of RNA-based Antifolate Predictive Response Signature (AF-PRS) to Guide Lung Cancer Treatment Selection
GeneCentric Therapeutics announced today the publication of initial results from the ongoing Piedmont study using real-world data in lung cancer to develop its novel RNA-based Antifolate Predictive Response Signature (AF-PRS), which is being co-developed as a clinical diagnostic test with Labcorp.
July 20, 2023
·
4 min read
1 of 10,747
Next
